| BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment? R Cohen, P Cervera, M Svrcek, A Pellat, C Dreyer, A de Gramont, T André Current treatment options in oncology 18, 1-14, 2017 | 73 | 2017 |
| Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology A Pellat, J Vaquero, L Fouassier Hepatology 67 (2), 762-773, 2018 | 69 | 2018 |
| Clinical and biomarker evaluations of sunitinib in patients with grade 3 digestive neuroendocrine neoplasms A Pellat, C Dreyer, C Couffignal, T Walter, C Lombard-Bohas, P Niccoli, ... Neuroendocrinology 107 (1), 24-31, 2018 | 62 | 2018 |
| Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer R Colle, A Radzik, R Cohen, A Pellat, D Lopez-Tabada, M Cachanado, ... European Journal of Cancer 144, 9-16, 2021 | 50 | 2021 |
| Well differentiated grade 3 neuroendocrine tumors of the digestive tract: a narrative review A Pellat, R Coriat Journal of Clinical Medicine 9 (6), 1677, 2020 | 36 | 2020 |
| Lynch syndrome: What is new? A Pellat, J Netter, G Perkins, R Cohen, F Coulet, Y Parc, M Svrcek, ... Bulletin du cancer 106 (7-8), 647-655, 2018 | 33 | 2018 |
| Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency R Cohen, A Pellat, H Boussion, M Svrcek, D Lopez-Trabada, I Trouilloud, ... Bulletin du Cancer 106 (2), 137-142, 2019 | 32 | 2019 |
| ESMO guidance for reporting oncology real-world evidence (GROW) L Castelo-Branco, A Pellat, D Martins-Branco, A Valachis, JWG Derksen, ... ESMO Real World Data and Digital Oncology 1, 100003, 2023 | 25 | 2023 |
| Therapeutic management of advanced hepatocellular carcinoma: an updated review M Falette Puisieux, A Pellat, A Assaf, C Ginestet, C Brezault, M Dhooge, ... Cancers 14 (10), 2357, 2022 | 25 | 2022 |
| Artificial intelligence: a review of current applications in hepatocellular carcinoma imaging A Pellat, M Barat, R Coriat, P Soyer, A Dohan Diagnostic and Interventional Imaging 104 (1), 24-36, 2023 | 23 | 2023 |
| Results of the national organised colorectal cancer screening program with FIT in Paris A Pellat, J Deyra, R Coriat, S Chaussade Scientific reports 8 (1), 4162, 2018 | 23 | 2018 |
| Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer R Cohen, V Jonchère, C De La Fouchardière, T Ratovomanana, ... Journal for Immunotherapy of Cancer 9 (2), 2021 | 22 | 2021 |
| Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling C Lobe, M Vallette, A Arbelaiz, E Gonzalez‐Sanchez, L Izquierdo, A Pellat, ... Hepatology 74 (6), 3194-3212, 2021 | 19 | 2021 |
| Chemotherapy in resected neuroendocrine carcinomas of the digestive tract: a National Study from the French Group of Endocrine Tumours A Pellat, T Walter, J Augustin, V Hautefeuille, O Hentic, C Do Cao, ... Neuroendocrinology 110 (5), 404-412, 2020 | 18 | 2020 |
| Multimodal management of grade 1 and 2 pancreatic neuroendocrine tumors U Marchese, M Gaillard, A Pellat, S Tzedakis, E Abou Ali, A Dohan, ... Cancers 14 (2), 433, 2022 | 17 | 2022 |
| Neuroendocrine carcinomas of the digestive tract: what is new? A Pellat, AS Cottereau, B Terris, R Coriat Cancers 13 (15), 3766, 2021 | 15 | 2021 |
| Digestive well-differentiated grade 3 neuroendocrine tumors: current management and future directions A Pellat, AS Cottereau, LJ Palmieri, P Soyer, U Marchese, C Brezault, ... Cancers 13 (10), 2448, 2021 | 15 | 2021 |
| Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma? MS Rémond, A Pellat, C Brezault, M Dhooge, R Coriat ESMO open 7 (6), 100638, 2022 | 13 | 2022 |
| The safety of long-term proton pump inhibitor use on cardiovascular health: a meta-analysis D Jeridi, A Pellat, C Ginestet, A Assaf, R Hallit, F Corre, R Coriat Journal of Clinical Medicine 11 (14), 4096, 2022 | 12 | 2022 |
| The role of magnetic resonance imaging in the management of esophageal cancer A Pellat, A Dohan, P Soyer, J Veziant, R Coriat, M Barret Cancers 14 (5), 1141, 2022 | 12 | 2022 |
